Table 2 Detailed breakdown of serum lithium concentration profile by site and source of requests
Lithium concentration (mmol/L) | Median (IQR) lithium concentration (mmol/L) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
< 0.1 | 0.1–0.39 | 0.4–0.59 | 0.6–0.79 | 0.8–0.99 | 1.0–1.39 | ≥1.4 | Total | ||
Site | |||||||||
PAT | 3.5% | 16.0% | 29.9% | 30.2% | 14.3% | 5.1% | 1.1% | 100.0% | 0.60 (0.44–0.76) |
SRFT | 3.3% | 17.5% | 32.6% | 29.9% | 12.0% | 3.9% | 0.8% | 100.0% | 0.58 (0.43–0.73) |
UHNM | 2.6% | 14.0% | 27.4% | 30.5% | 17.9% | 6.4% | 1.2% | 100.0% | 0.63 (0.47–0.80) |
Total | 3.2% | 16.0% | 30.1% | 30.2% | 14.4% | 5.1% | 1.0% | 100.0% | 0.60 (0.44–0.76) |
Source | |||||||||
GP | 53.7% | 47.7% | 57.2% | 60.0% | 60.6% | 53.7% | 24.4% | 56.4% | 0.61 (0.46–0.76) |
MHU | 31.3% | 39.1% | 35.6% | 33.9% | 32.4% | 28.3% | 11.1% | 34.4% | 0.58 (0.42–0.74) |
Acute care | 4.5% | 3.0% | 1.5% | 1.1% | 1.8% | 6.0% | 38.0% | 2.4% | 0.66 (0.38–1.10) |
Secondary care | 9.3% | 9.2% | 5.0% | 4.3% | 4.7% | 11.3% | 25.9% | 6.1% | 0.53 (0.34–0.75) |
Other | 1.3% | 1.0% | 0.6% | 0.7% | 0.5% | 0.7% | 0.6% | 0.7% | 0.57 (0.38–0.68) |
Total | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |